Chat
+91 9041725050
9.30 am - 5.30 pm Mon to Sat
Request Callback
  • Login
  • Sign up
    • Home
      • About Us
      • Company Profile
    • Events
      • Cinnamon Seminar
      • CPEIS-2026
      • Flow Chemistry India 2026 (FCI26)
      • Past Events
    • Event Sciences
      • Conference Management
      • Physical Events
      • Virtual Events
      • Tech. Exhibitions
      • Networking
      • Sponsorship
      • Oral/Poster Presentation
    • Resources
      • Blogs
    • Gallery
    • Contact Us

    Revolutionizing Portfolio Selection

    Overview 

    Portfolio selection defines the trajectory of a pharmaceutical company, shaping both short-term performance and long-term success. In the competitive generic space, a "winning selection" is paramount for profitability. However, companies often spend months, consuming countless man-hours and expensive databases, to analyze raw data. This over-analysis results in inefficiency, hindering strategic execution.

    This webinar addresses the critical need for swift, efficient, and productive portfolio management/selection, emphasizing optimum analysis to save time and effort. We will cover important elements of product portfolio development and showcase an ingenious way to achieve desired goals through effective portfolio selection and strategic short- and long-term planning.

    Further, Risk Assessment and Management is an important approach towards strategic decision making. This session will see discussions on the role data based risk assessment plays in key decision making. For Pharma companies in the international arena, portfolio development is an excellent example where data based risk assessments play a huge role in potential success of the strategy. Good data along with efficiencies in time involved in risk assessment can lead to better portfolio building.

    What You Will Learn

    This 2-hour Webinar-cum-Workshop will provide a demo of the HORIZONS® platform (The ONLY Tool that saves 90-95% time and 60-70% on costs in Portfolio Management and Portfolio Selection), showcasing the latest means to achieve portfolio development objectives. Using key parameters, algorithms, and AI, participants will learn how to generate a portfolio in seconds, empowering teams to focus on actioning the selection process, rather than being bogged down by the selection itself. This addresses the limitations of other platforms (e.g., IPD Analytics) by offering dynamic search, real-time analytics, and customizable features.

    This Webinar-cum-Workshop will be held on April 17, 2025, virtually (2.30 pm to 4.30 pm) IST.

    Exclusive Offers

    Free Trial Access: All webinar attendees (*who attend the complete webinar) will receive free trial access to the HORIZONS® platform.

    10% Discount: Receive a 10% discount on all HORIZONS® subscriptions signed within 15 days of the event!

    Don't miss this opportunity to learn how HORIZONS® can transform your portfolio selection process and drive success for your organization! Plus, take advantage of our exclusive offers to experience the power of HORIZONS® firsthand.

    Who Should Attend

    Heads of Portfolio/Strategy/IP/Licensing/R&D specifically working in Product Selection of the generic pharmaceutical industry.

    MDs/CEOs/Head-BD/Head-R&D engaged in product/portfolio selections and strategy of the mid-size generic pharmaceutical industry.

    MDs/CEOs/Head-BD/Head-R&D from Regulatory/Dossier developing organizations engaged in product/portfolio selection and strategy.

    MDs/CEOs/Head-BD/Head-R&D from CRO's engaged in product/portfolio selection and strategy.

    Contacts

    Technical Query: Ms. Tavleen Thakur, M: 7696125050, Email: t.thakur@glostem.com
    Participation Query: Ms. Swati Kanwar, M: 8289015050, Email: s.kanwar@glostem.com
                                      Ms. Farheen, M: 7696225050, Email: f.zainab@glostem.com

    Conference Date

    17-04-2025

    Avijit Kelkar
    Avijit Kelkar
    Co-founder - Aharav Consultants, Langley, UK
    Sharad Tyagi
    Sharad Tyagi
    CEO and Co-founder - Tiyash Consulting, India

    Avijit Kelkar's Biography

    Avijit Kelkar

    Co-founder

    Aharav Consultants

    Dr Avijit Kelkar is a Product / Portfolio and IP strategist, who started Aharav consultants firm in May 2018 after heading Portfolio Strategy and IP with top generic companies such as Dr Reddys, and Sun Pharma. Avijit brings broad range of technical expertise in product selection and strategic risk assessment, bioequivalence in drug development, in combination of his experience in patent and Trademark litigation, patent drafting and invalidation. He is a Post Doctorate in Organic Chemistry, a European Patent practitioner and a GDPR practitioner / consultant for last 4 years and specializes in pharma- GDPR. Avijit is a Co-founder at Aharav consultants, and the main creator conceptualisor of HORIZONS - a portfolio management and strategy platform, which helps companies in product selection and portfolio creation in few hours, thereby saving 99% of time.

     


    Sharad Tyagi's Biography

    Sharad Tyagi

    CEO and Co-founder

    Tiyash Consulting

    Sharad Tyagi, CEO and Co-founder of Tiyash Consulting, has over 35 years of global experience in pharma, OTC, automotive catalysts, and specialty chemicals. He excels in building profitable, high-growth organizations. Formerly MD of Boehringer Ingelheim India until December 2021, Sharad’s past roles include SVP at DRL and Director of Strategy at Engelhard and ICL. He is based in Mumbai, India.


    Horizon
    Horizon

    Upcoming Conferences

    AI, and ML in Pharmaceutical R&D and Manufacturing Workflows
    23 - 24 Apr, 2026

    Cinnamon Seminar

    Details
    AI, and ML in Pharmaceutical R&D and Manufacturing Workflows
    14 - 15 May, 2026

    CPEIS-2026

    Details
    AI, and ML in Pharmaceutical R&D and Manufacturing Workflows
    10 - 11 Sep, 2026

    Flow Chemistry India 2026 (FCI26)

    Details

    Speakers & Panelists

    Avijit Kelkar

    Avijit Kelkar's Biography

    Avijit Kelkar

    Co-founder

    Aharav Consultants

    Dr Avijit Kelkar is a Product / Portfolio and IP strategist, who started Aharav consultants firm in May 2018 after heading Portfolio Strategy and IP with top generic companies such as Dr Reddys, and Sun Pharma. Avijit brings broad range of technical expertise in product selection and strategic risk assessment, bioequivalence in drug development, in combination of his experience in patent and Trademark litigation, patent drafting and invalidation. He is a Post Doctorate in Organic Chemistry, a European Patent practitioner and a GDPR practitioner / consultant for last 4 years and specializes in pharma- GDPR. Avijit is a Co-founder at Aharav consultants, and the main creator conceptualisor of HORIZONS - a portfolio management and strategy platform, which helps companies in product selection and portfolio creation in few hours, thereby saving 99% of time.

     


    Co-founder,  Aharav Consultants,
    Langley, UK

    Sharad Tyagi

    Sharad Tyagi's Biography

    Sharad Tyagi

    CEO and Co-founder

    Tiyash Consulting

    Sharad Tyagi, CEO and Co-founder of Tiyash Consulting, has over 35 years of global experience in pharma, OTC, automotive catalysts, and specialty chemicals. He excels in building profitable, high-growth organizations. Formerly MD of Boehringer Ingelheim India until December 2021, Sharad’s past roles include SVP at DRL and Director of Strategy at Engelhard and ICL. He is based in Mumbai, India.


    CEO and Co-founder,  Tiyash Consulting,
    India

    Conference Sponsors

    Sponsor
    Horizon
    Horizon

    Horizon

    Horizon


    Registrations for this conference is closed now.

    Registration

    Registration categories will be published here.

    Menu

    • Home
    • About Us
    • Company Profile
    • Contact Us

    Contact Us

    Unit 21, Level 2, Berkeley Square, Plot No 24, Industrial & Business Park, Phase I, Chandigarh 160002, India

    events@glostem.in

    +91 172 5025050, 9041725050

    • Privacy Policy
    • Terms & Conditions
    • Cancellation & Refund Policy
    © Copyright 2025 Glostem Private Limited. All rights reserved.
    Site Created & Maintained by Digilinkers